The estimated Net Worth of Robert T. Jr. Davis is at least $5.58 Millón dollars as of 6 March 2024. Mr. Davis owns over 8,736 units of Integra Lifesciences Corp stock worth over $1,025,042 and over the last 12 years he sold IART stock worth over $3,160,942. In addition, he makes $1,390,400 as Executive Vice President y President - Orthopedics and Tissue Technologies at Integra Lifesciences Corp.
Robert has made over 5 trades of the Integra Lifesciences Corp stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 8,736 units of IART stock worth $284,706 on 6 March 2024.
The largest trade he's ever made was selling 24,941 units of Integra Lifesciences Corp stock on 25 February 2021 worth over $1,732,901. On average, Robert trades about 1,560 units every 78 days since 2013. As of 6 March 2024 he still owns at least 58,241 units of Integra Lifesciences Corp stock.
You can see the complete history of Mr. Davis stock trades at the bottom of the page.
Robert T. Davis Jr. serves as Executive Vice President, President - Orthopedics and Tissue Technologies of the Company. Mr. Davis is responsible for the management of the Orthopedics and Tissue Technologies global division, which includes orthopedic extremity implants and regenerative tissue products. His responsibilities include leadership of sales, commercial operations, marketing and strategy, product development, regulatory affairs, quality assurance, manufacturing services and repair, and business development of the orthopedic extremity implants and regenerative tissue portfolio. Mr. Davis joined Integra in July 2012 as President of the global neurosurgery business and was appointed Integra’s Corporate Vice President in December 2012 and President — Specialty Surgical Solutions in 2014. He brings more than 25 years of executive management experience in the global healthcare industry. Prior to joining Integra, Mr. Davis was the general manager for the global anesthesia & critical care business at Baxter Healthcare and held various general management positions at GE Healthcare in the areas of interventional therapeutics, cardiovascular imaging and diagnostic ultrasound. Mr. Davis earned his B.S. in Sports Medicine from the University of Delaware, a Master’s degree in Exercise & Cardiovascular Physiology from Temple University, and an M.B.A. from Drexel University.
As the Executive Vice President y President - Orthopedics and Tissue Technologies of Integra Lifesciences Corp, the total compensation of Robert Davis at Integra Lifesciences Corp is $1,390,400. There are 4 executives at Integra Lifesciences Corp getting paid more, with Peter Arduini having the highest compensation of $7,859,420.
Robert Davis is 61, he's been the Executive Vice President y President - Orthopedics and Tissue Technologies of Integra Lifesciences Corp since 2019. There are 7 older and 14 younger executives at Integra Lifesciences Corp. The oldest executive at Integra Lifesciences Holdings Corp is Dr. Richard E. Caruso, 78, who is the Founder and Chairman Emeritus.
Robert's mailing address filed with the SEC is 1100 CAMPUS ROAD, , PRINCETON, NJ, 08540.
Over the last 22 years, insiders at Integra Lifesciences Corp have traded over $397,927,161 worth of Integra Lifesciences Corp stock and bought 132,879 units worth $4,504,827 . The most active insiders traders include Neal Moszkowski, Stuart Essig y George Soros. On average, Integra Lifesciences Corp executives and independent directors trade stock every 19 days with the average trade being worth of $668,131. The most recent stock trade was executed by Jeffrey Mosebrook on 19 August 2024, trading 1,191 units of IART stock currently worth $25,702.
integra lifesciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. in the united states, integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. founded in 1989 integra is headquartered in plainsboro, new jersey and has over 3,500 employees worldwide. integra's common stock is li
Integra Lifesciences Corp executives and other stock owners filed with the SEC include: